Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 115,584 shares at $51.13 ($5.9M) on 2018-11-08, disclosed to the SEC on 2018-11-13.
Open-market sale of $5.9M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.13 | 57,339 | $2.9M | 49.6% |
| 2 | $51.13 | 57,339 | $2.9M | 49.6% |
| 3 | $50.23 | 906 | $46K | 0.8% |
| Total | $51.12 avg | 115,584 | $5.9M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |